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SPECIFIC AIMS
The aim of this study was to examine the role of the
phospholipase A2/arachidonic acid cascade in apopto-
sis of human coronary artery endothelial cells caused by
specific polycyclic aromatic hydrocarbons (PAHs)
present in high concentrations in cigarette smoke.
Identification of specific components of cigarette
smoke that alter pathways known to be important in
heart disease will likely provide means for discovering
effective preventative and therapeutic strategies in
smokers.
PRINCIPAL FINDINGS
1. PAHs induce release of 3H-arachidonic acid or
3H-linoleic acid from human coronary artery
endothelial cells
Release of 3H-arachidonic acid from prelabeled cells
was used as a measure of PLA2 activity in response to
three different PAHs present in high concentrations in
cigarette smoke: 1-methylanthracene (1-MA; 1500 ng/
cigarette), benzo(a)pyrene (B(a)P; 25 ng/cigarette),
and phenanthrene (PA; 362 ng/cigarette). When en-
dothelial cells were incubated for 1 h with various
concentrations of 1-methylanthracene, benzo(a)pyrene,
or phenanthrene, all three compounds caused concen-
tration-dependent release of 3H-arachidonic acid.
1-Methylanthracene and phenanthrene also induced
release of 3H-linoleic acid, suggesting that these com-
pounds activate an arachidonyl-nonselective PLA2. In
contrast, benzo(a)pyrene did not cause release of 3H-
linoleic acid, suggesting that this compound activates
an arachidonyl-selective enzyme. Significant release of
3H-arachidonic acid was observed within 5 min from
cells exposed to phenanthrene (30 M) and within 10
min from cells exposed to 1-methylanthracene (30 M)
or benzo(a)pyrene (30 M).
2. Specific PLA2 inhibitors attenuate PAH-induced
release of 3H-arachidonic acid from human coronary
artery endothelial cells
PAH-induced release of 3H-arachidonic acid was evalu-
ated in the presence and absence of inhibitors of
selective isoforms of PLA2. Methyl-arachidonyl fluoro-
phosphonate (MAFP), an inhibitor of group IV and
group VI enzymes, inhibited 3H-arachidonic acid re-
leased in response to all three PAHs. Bromoenol lac-
tone (BEL), a selective inhibitor of group VI calcium-
independent PLA2 (iPLA2), attenuated the response to
1-methylanthracene and phenanthrene, but not benzo-
(a)pyrene. MJ33, an inhibitor of the acidic, calcium-
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Figure 1. Attenuation of PAH-induced 3H-arachidonic acid
release by PLA2 inhibitors in human coronary artery endo-
thelial cells.
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independent PLA2, aiPLA2 inhibited
3H-arachidonic
acid release in response to phenanthrene but not
1-methylanthracene or benzo(a)pyrene (Fig. 1). 4-Bro-
mophenacyl bromide, an inhibitor of small molecular
weight, calcium-dependent PLA2s, did not alter the
response to any PAH. Reverse transcriptase-polymerase
chain reaction analysis of PLA2 isoforms indicates that
human coronary artery endothelial cells contain mRNA
for at least five different PLA2 isozymes: groups IV,
IV, IV, group VI, and the acidic, calcium-indepen-
dent PLA2. Western analysis confirmed the presence of
four of these enzymes: group IV , IV, group VI, and
the lysosomal, acidic, calcium-independent PLA2.
3. PAHs induce apoptosis of human coronary artery
endothelial cells
Apoptosis was evaluated by three techniques: Western
analysis for the cleavage product of poly(ADP) ribose
polymerase (PARP), ELISA for histone fragmentation,
and terminal deoxyribonucleotide nick-end labeling
(TUNEL). There was no evidence of PARP cleavage in
vehicle-treated cells; however, significant amounts of
the cleavage fragments were observed in cells after
treatment for 6 h with 30 M 1-methylanthracene,
benzo(a)pyrene, phenanthrene, or 10 M arachidonic
acid or linoleic acid. To evaluate the time course of
apoptosis, TUNEL assays were performed. No apopto-
tic cells were observed at 60 min, but a significant
number of TUNEL-positive cells were seen at 2 h after
treatment with the PAHs or fatty acids. For a more
quantitative measure of PAH-induced apoptosis, his-
tone fragmentation was evaluated by ELISA. These
studies were performed in the presence and absence of
MAFP, BEL, and MJ33. As can be seen in Fig. 2, the
same inhibitor profile observed for 3H-arachidonic acid
release was seen with the apoptotic response. The
response to 1-methylanthracene was attenuated by
MAFP and BEL, but not MJ33. In contrast, the response
to phenanthrene was inhibited by all three inhibitors,
but benzo(a)pyrene-induced apoptosis was inhibited
only by MAFP.
CONCLUSIONS
It is well known from epidemiologic studies that the
PLA2/arachidonic acid cascade is important in the
mechanism whereby cigarette smoking causes heart
disease; however, little work has focused on identifying
specific components of cigarette smoke responsible for
this effect. This study is the first to identify specific
PAHs in high concentrations in cigarette smoke that
stimulate PLA2-mediated release of membrane fatty
acids. These results suggest that three distinct isoforms
of PLA2 are activated by three different PAHs. The data
indicate that 1-methylanthracene, a three-ring com-
pound, activates the group VI iPLA2 whereas benzo-
(a)pyrene, a five-ring compound, activates a group IV
enzyme. In contrast, phenanthrene, with a four-mem-
bered ring, activates both group VI and the acidic
iPLA2. Moreover, this study is the first to link expo-
sure of endothelial cells to cigarette smoke compo-
nents with PLA2 activation, fatty acid release, and
apoptosis, events known to be important in the
etiology of atherosclerosis.
Figure 2. Inhibition of PAH-induced apoptosis of human
coronary artery endothelial cells by PLA2 inhibitors.
Figure 3. Schematic diagram.
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